India's most comprehensive portal on pharmaceutical News, Tenders, Patents, Notifications, Projects, Stocks, Drugs & Medicines

US FDA accepts Medivir's IND application for MIV-711

Join Pharma | Login

	Editorial


	THREAT OF API AVAILABILITY
	Thursday, August 17, 2017
	India’s main worry today should be the danger China can pose to the domestic pharmaceutical production as the trouble in the Indo-China border is only escalating.
	Past Editorial...

TODAY'S NEWS


09:00 [IST]	US FDA accepts Medivir's IND application for MIV-711

more news >>

TOP NEWS


08:00 [IST]	Poor implementation of online tracking of drugs at ports hits industry badly
08:00 [IST]	Universities flaunting UGC, PCI norms, Pharm-D students deprived of ‘Dr’ tag
08:00 [IST]	Academic experts want AICTE to give one-time approval to the Pharm D programmes being conducted by various colleges
08:00 [IST]	Karnataka govt gears up to provide telemedicine consultation at all its 2,346 PHCs & 326 CHCs
08:00 [IST]	Metropolis to invest Rs.100 crore to enhance footprint pan India
08:00 [IST]	ICMR to launch programme to develop/scale up innovative, cost effective & sustainable models to engage private sector for TB elimination

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Shuttle Pharma, POLA Pharma enter pact to license US rights for doranidazole
17:40 [IST]	J&J partners with CSIR-IMTECH to develop innovative new tuberculosis treatments
17:00 [IST]	Bristol-Myers Squibb reports positive results from CheckMate -214 phase 3 study of Opdivo in combo with Yervoy to treat advanced/metastatic RCC
16:40 [IST]	Sri Ramachandra University, Chennai to start two new para-medical courses in this academic year
16:00 [IST]	EnvoyHealth signs co-marketing partnership with PharMedQuest for ARC medical benefit drug management platform
15:45 [IST]	ISF College of Pharmacy, Moga launches risk screening project

more news >>

INTERVIEW


New stent pricing to help improve top and bottom lines
Swaminathan Jayaraman, Chairman and Managing Director,

Past Interviews...

	What's New?

Apollo Hospitals standalone net falls by over 51% in Q1 to Rs.35 cr Suven Life Sciences net dips by 9.2% in Q1 Strides Shasun net declines sharply by 86% in Q1 Laurus Labs net jumps by 52% in Q1 Sun Pharma incurred heavy net loss of Rs.323 crore in Q1, sales declines by 23%

Opinion Poll

Is the Union Health Ministry’s proposal to amend DC Rules to make only registered pharmacists eligible for wholesale licenses justified ?

YesNoCan't Say

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers